Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption. (2021). Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021022. https://doi.org/10.4084/mjhid.2021.022